Remove null
article thumbnail

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

Medical Xpress

A one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) therapy by the University of Sydney did not lead to lower rates of skin cancer in organ transplant recipients.

Trials 74
article thumbnail

New research partnership

Scienmag

publishers, in their continued efforts to advance the publication of research with negative findings, announced today the launch of Neurotrauma Reports Null Hypothesis at the 10th Annual Traumatic […]. Credit: Mary Ann Liebert, Inc.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Industry Payments Consistently Linked to Physician Prescribing

The Pharma Data

The researchers found that 30 of the studies identified a positive association between payments and prescribing in all analyses, while six studies had a mix of positive and null findings. None of the studies reported only null findings. A positive association was identified in 89 of the 101 individual analyses.

article thumbnail

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

The study found a null effect on HbA1c. There were no significant drops in cholesterol, triglycerides, or fasting glucose and weight did not lower. There was not a statistically significant difference between the 2 groups at 12 months. The study did find substantial effects on diet and healthcare engagement. Learn more Read more in JAMA.

article thumbnail

Regeneron’s cholesterol drug evinacumab claims February FDA date

pharmaphorum

Crucially, Regeneron’s drug seems to work even in so-called ‘null-null’ patients, which have very low levels of receptors that remove LDL cholesterol from the blood and so progress to cardiovascular complications very quickly.

Drugs 52
article thumbnail

Dynamic Reports – A How-to Guide

Cloudbyz

We made this parameter null so that we can pass the Account Name value (field value) into the filter from our button. Null is where you input the parameter from account to case. On top of this, you will be adding more custom filters and filter logic to build your desired report. Then, hit ‘Save & Run’ and name your report.,

article thumbnail

Taking responsibility for changing lives: Sharing data and accelerating access

pharmaphorum

To avoid duplication, we need to make sure that null result studies and negative results are openly available,” said Perrin, adding that it all comes back to using charity funds in the way that will best benefit patients. You need to build on others’ results, so that you’re not starting again from the beginning. “To